Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Merit Medical Systems (MMSI) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Merit Medical Systems (MMSI) over the last 16 years, with Q3 2025 value amounting to -$4.1 million.

  • Merit Medical Systems' Non Operating Income fell 57417.22% to -$4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.1 million, marking a year-over-year decrease of 21782.65%. This contributed to the annual value of -$5.7 million for FY2024, which is 5191.9% up from last year.
  • As of Q3 2025, Merit Medical Systems' Non Operating Income stood at -$4.1 million, which was down 57417.22% from -$3.5 million recorded in Q2 2025.
  • Over the past 5 years, Merit Medical Systems' Non Operating Income peaked at $997000.0 during Q1 2023, and registered a low of -$6.0 million during Q4 2022.
  • In the last 5 years, Merit Medical Systems' Non Operating Income had a median value of -$2.0 million in 2021 and averaged -$2.3 million.
  • As far as peak fluctuations go, Merit Medical Systems' Non Operating Income soared by 19387.95% in 2023, and later plummeted by 329902.91% in 2025.
  • Over the past 5 years, Merit Medical Systems' Non Operating Income (Quarter) stood at -$1.7 million in 2021, then tumbled by 251.37% to -$6.0 million in 2022, then surged by 64.4% to -$2.1 million in 2023, then tumbled by 59.39% to -$3.4 million in 2024, then dropped by 19.1% to -$4.1 million in 2025.
  • Its Non Operating Income was -$4.1 million in Q3 2025, compared to -$3.5 million in Q2 2025 and -$3.1 million in Q1 2025.